Skip to main content
Clinical Trials/NCT05496985
NCT05496985CompletedNot Applicable

Chinese Validation of the Simplified Evaluation of CONsciousness Disorders(SECONDs)

Hangzhou Normal University1 site in 1 country49 target enrollmentStarted: December 20, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
49
Locations
1
Primary Endpoint
Assess the reliability and validity of the Chinese version of the SECONDs

Study Overview

Brief Summary

The aim of this study was to translate the SECONDs from French into Chinese and assess the validity and reliability of the Chinese version of the SECONDs .

Detailed Description

To promote accurate assessments of DoC patients and the development of clinical research on DoC in China, we here propose and validate a version of the SECONDs translated into Mandarin Chinese. Hence, this study aims to assess the concurrent validity (compared with the CRS-R which has already been translated and validated in Mandarin), intra-rater reliability, and inter-rater reliability of the Chinese version of the SECONDs

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
Single (Outcomes Assessor)

Masking Description

Until the end of the protocol, all three assessors were blinded to the scores acquired by the other assessors.

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Acute (longer than 14 days, less than 28 days) or prolonged DoC (following severe acquired brain injury, longer than 28 days);
  • Age: 18-85 years old;
  • No history of other neurological or psychiatric deficits;
  • Ability to speak Chinese fluently;
  • Medical stability (e.g., absence of mechanical ventilation, sedation, infection)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Assess the reliability and validity of the Chinese version of the SECONDs

Time Frame: Within 10 days

The reliability and validity of the Chinese version of the SECONDs were evaluated by calculating the weighted Cohen's Kappa and Spearman coefficients of the differences between SECONDs and CRS-R in the diagnosis of MCS and UWS patients

Diagnose the level of consciousness in patients through SECONDs and CRS-R

Time Frame: Within 10 days

Detect acute (longer than 14 days, less than 28 days) or prolonged DoC (following severe acquired brain injury, longer than 28 days) patients through Simplified Evaluation of CONsciousness Disorders (SECONDs).

Diagnose the level of consciousness in patients through CRS-R

Time Frame: Within 10 days

Detect acute (longer than 14 days, less than 28 days) or prolonged DoC (following severe acquired brain injury, longer than 28 days) patients through Coma Recovery Scale-Revised (CRS-R).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Hangzhou Normal University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Haibo Di

professor

Hangzhou Normal University

Study Sites (1)

Loading locations...

Similar Trials